Literature DB >> 8460409

Heparin improves oxygenation and minimizes barotrauma after severe smoke inhalation in an ovine model.

C S Cox1, J B Zwischenberger, D L Traber, L D Traber, A K Haque, D N Herndon.   

Abstract

Inhalation injury is one of the main causes of mortality in burn victims. The tracheobronchial epithelium sloughs and combines with a protein rich exudate to form casts of the airways that can lead to obstruction. We studied the effects of a continuous infusion of heparin on the acute pulmonary injury that occurs after smoke inhalation injury in sheep. Twelve ewes with vascular catheters received a standardized smoke inhalation injury and mechanical ventilation according to protocol for 72 hours. The heparin group (n = 6) received a 400 unit per kilogram bolus of heparin followed by a continuous infusion to maintain the activated clotting time between 250 to 300 seconds. The control group (n = 6) received a saline solution vehicle. Hemodynamics, blood gases and plasma samples for conjugated dienes were taken every six hours. At necropsy, pulmonary tissue was collected for histologic findings, polymorphonuclear neutrophil leukosequestration, wet-to-dry weight ratios and conjugated dienes. PaO2 to FIO2 ratios were improved in the heparin group compared with the control group at 12 to 72 hours after injury, and peak airway pressures were higher in the control group compared with the heparin group. Positive end expiratory pressure requirements were higher in the control group compared with the heparin group. There were significantly fewer airway tracheobronchial casts as determined by our tracheobronchial casts scoring system (2.4 +/- 0.4 versus 0.67 +/- 0.21) and confirmed by histologic examination. Pulmonary blood-free wet-to-dry weight ratios were higher in the control group compared with the heparin group (6.4 +/- 0.5 versus 5.2 +/- 0.1; p < 0.05). There were no differences in pulmonary tissue or plasma conjugated dienes; likewise, pulmonary leukosequestration was unaffected by heparin. Heparin decreases tracheobronchial cast formation, improves oxygenation, minimizes barotrauma and reduces pulmonary edema in an ovine model of severe smoke inhalation injury. Heparin does not reduce oxygen free radical activity after smoke inhalation injury.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8460409

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  16 in total

1.  Pulmonary coagulopathy: a potential therapeutic target in different forms of lung injury.

Authors:  Marcus J Schultz; Marcel Levi
Journal:  Thorax       Date:  2007-07       Impact factor: 9.139

Review 2.  The cornerstones and directions of pediatric burn care.

Authors:  S E Wolf; M Debroy; D N Herndon
Journal:  Pediatr Surg Int       Date:  1997-07       Impact factor: 1.827

Review 3.  Inhalation Injury in the Burned Patient.

Authors:  Guillermo Foncerrada; Derek M Culnan; Karel D Capek; Sagrario González-Trejo; Janos Cambiaso-Daniel; Lee C Woodson; David N Herndon; Celeste C Finnerty; Jong O Lee
Journal:  Ann Plast Surg       Date:  2018-03       Impact factor: 1.539

4.  Impact of bronchial circulation on bronchial exudates following combined burn and smoke inhalation injury in sheep.

Authors:  Naoki Morita; Perenlei Enkhbaatar; Dirk M Maybauer; Marc O Maybauer; Martin Westphal; Kazunori Murakami; Hal K Hawkins; Robert A Cox; Lillian D Traber; Daniel L Traber
Journal:  Burns       Date:  2010-12-30       Impact factor: 2.744

5.  Heparin reduced mortality and sepsis in severely burned children.

Authors:  G J Zayas; A M Bonilla; M J Saliba
Journal:  Ann Burns Fire Disasters       Date:  2007-03-31

Review 6.  [Pathophysiology of acute lung injury in severe burn and smoke inhalation injury].

Authors:  M O Maybauer; S Rehberg; D L Traber; D N Herndon; D M Maybauer
Journal:  Anaesthesist       Date:  2009-08       Impact factor: 1.041

7.  Pulmonary expression of nitric oxide synthase isoforms in sheep with smoke inhalation and burn injury.

Authors:  Robert A Cox; Sam Jacob; Gloria Oliveras; Kazunori Murakami; Perenlei Enkhbaatar; Lillian Traber; Frank C Schmalstieg; David N Herndon; Daniel L Traber; Hal K Hawkins
Journal:  Exp Lung Res       Date:  2009-03       Impact factor: 2.459

Review 8.  Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome.

Authors:  Robert MacLaren; Kathleen A Stringer
Journal:  Pharmacotherapy       Date:  2007-06       Impact factor: 4.705

9.  Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome: a retrospective propensity matched cohort study.

Authors:  Jorrit J Hofstra; Alexander P J Vlaar; David J Prins; Gavin Koh; Marcel Levi; Marcus J Schultz; Jan M Binnekade; Nicole P Juffermans
Journal:  BMC Pulm Med       Date:  2012-08-15       Impact factor: 3.317

10.  Pharmaco-management of inhalation injuries for burn survivors.

Authors:  Anthony C Bartley; Dale W Edgar; Fiona M Wood
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.